Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003931 · ClinicalTrials.gov registry record
Diagnostic Study of Gene Alterations in Patients With Acute Myeloid Leukemia
A clinical trial, sponsored by Alliance for Clinical Trials in Oncology.
- Completed
- Registry status
- 9,769
- Enrollment target
NCT00003931: Completed study, sponsored by Alliance for Clinical Trials in Oncology.
NCT00003931 is a clinical trial that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 9,769 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00003931 has completed, sponsored by Alliance for Clinical Trials in Oncology.
- COMPLETED
- Registry status
- 9,769 participants
- Enrollment target
Study Summary
RATIONALE: Diagnostic procedures, such as genetic testing, may improve the ability to detect acute myeloid leukemia and determine the extent of disease. PURPOSE: Diagnostic study to try to detect changes in the genes of patients who have acute myeloid leukemia.
Interventions
- GENETIC reverse transcriptase-polymerase chain reaction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9,769 participants |
| Start Date | 1999-02 |
| Est. Completion | 2006-06 |
What the finished NCT00003931 record still lists
NCT00003931 is an observational study that tracks outcomes without assigning an intervention. Its 9,769 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which reverse transcriptase-polymerase chain reaction is the first listed.
NCT00003931 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00003931 about?
NCT00003931 is a clinical study titled "Diagnostic Study of Gene Alterations in Patients With Acute Myeloid Leukemia". RATIONALE: Diagnostic procedures, such as genetic testing, may improve the ability to detect acute myeloid leukemia and determine the extent of disease. PURPOSE: Diagnostic study to try to detect changes in the genes of patients who have acute myeloid leukemia.
What is the current status of trial NCT00003931?
This trial is currently completed. The enrollment target is 9,769 participants. The study started on 1999-02. Estimated completion is 2006-06.
What interventions are being tested in trial NCT00003931?
The interventions under investigation include: reverse transcriptase-polymerase chain reaction (GENETIC).
Who is sponsoring clinical trial NCT00003931?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00160771 · 10,000 participants
Biomechanics/Motion Analysis Laboratory Data Bank
- NCT00896935 · 10,000 participants
Arizona Cancer Center Biospecimen Repository
- NCT00898235 · 10,000 participants
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
- NCT00992303 · 10,000 participants
Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia